A. Lamy
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 3
-
- Protein Tyrosine Phosphatases 1
- Co-authors
- Thierry Frébourg (7 shared papers)Frédéric Blanchard (4 shared papers)Pierre Michel (3 shared papers)F. Charbonnier (3 shared papers)Florence Le Pessot (3 shared papers)Frédéric Di Fiore (4 shared papers)B Paillot (2 shared papers)A M Queuniet (1 shared paper)
In The Last Decade
A. Lamy
9 papers receiving 764 citations
A. Lamy's Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 646
- Hepatology 125
- Pathology and Forensic Medicine 266
- Pulmonary and Respiratory Medicine 303
- Cancer Research 138
Countries citing papers authored by A. Lamy
This map shows the geographic impact of A. Lamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lamy more than expected).
Fields of papers citing papers by A. Lamy
This network shows the impact of papers produced by A. Lamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lamy. The network helps show where A. Lamy may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Lamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy Hit paper breakdown → | 2007 | 621 |
| 2 | 2009 | 72 | |
| 3 | 2006 | 54 | |
| 4 | 2008 | 18 | |
| 5 | 2007 | 6 | |
| 6 | 2011 | 5 | |
| 7 | 2024 | 5 | |
| 8 | 2012 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2025 | 0 |
About A. Lamy
A. Lamy is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Hepatology, having authored 10 papers that have together received 783 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Genetic factors in colorectal cancer (2 papers), Lung Cancer Treatments and Mutations (2 papers), Protein Tyrosine Phosphatases (1 paper) and Biochemical Analysis and Sensing Techniques (1 paper). The work is most often cited by research in Oncology (646 citations), Hepatology (125 citations), Pathology and Forensic Medicine (266 citations), Pulmonary and Respiratory Medicine (303 citations) and Cancer Research (138 citations). A. Lamy has collaborated with scholars based in France, Belgium and Sweden. Frequent co-authors include Thierry Frébourg, Frédéric Blanchard, Pierre Michel, F. Charbonnier, Florence Le Pessot, Frédéric Di Fiore, B Paillot, A M Queuniet, Jean‐Jacques Tuech and Jean‐Christophe Sabourin. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, International Journal of Molecular Sciences and Journal of Chemical Information and Modeling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.